Drug General Information
Drug ID	D0MQ8A
Former ID	DNC010141
Drug Name	3-butyl-3-ethyl-1-phenylazetidine-2,4-dione
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530511]
Structure		Download 2D MOL 3D MOL
Formula	C15H19NO2
Canonical SMILES	CCCCC1(C(=O)N(C1=O)C2=CC=CC=C2)CC
InChI	1S/C15H19NO2/c1-3-5-11-15(4-2)13(17)16(14(15)18)12-9-7-6-8-10-12/h6-10H,3-5,11H2,1-2H3
InChIKey	OMJBWYRKWVXDDX-UHFFFAOYSA-N
PubChem Compound ID	20283207
Target and Pathway
Target(s)	Leukocyte elastase	Target Info	Inhibitor	[530511]
KEGG Pathway	Transcriptional misregulation in cancer
	Systemic lupus erythematosus
Pathway Interaction Database	Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
	C-MYB transcription factor network
Reactome	Collagen degradation
	Degradation of the extracellular matrix
	Activation of Matrix Metalloproteinases
WikiPathways	Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
	Human Complement System
	Degradation of collagen
References
Ref 530511	J Med Chem. 2010 Jan 14;53(1):241-53.4-Oxo-beta-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase.
Ref 530511	J Med Chem. 2010 Jan 14;53(1):241-53.4-Oxo-beta-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.